Stoke TherapeuticsNASDAQ: STOK: Develops RNA-based therapies for severe genetic disorders.
10+ YOE5+ Mgmt10+ years CMC experience with drug-device combination products, 5+ years CMC leadership, bachelor's required (advanced degree preferred), deep CMC/regulatory knowledge, strong communication and cross-functional leadership.
Rhythm PharmaceuticalsNASDAQ: RYTM: Develops precision medicines for rare neuroendocrine and obesity diseases.
10+ YOEBS in life sciences, 10+ years regulatory CMC or related pharma experience, experience with peptides and injectable dosage forms, ability to author CMC submissions and coordinate cross-functional inputs.
Genetix Biotherapeutics: Developing and commercializing curative gene therapies for rare diseases.
10+ YOE10+ years biopharma CMC regulatory experience for biologics/gene therapies; bachelor’s or master’s in life sciences; experience with post-approval CMC submissions, GMP and global regulatory frameworks; strong communication and cross-functional skills.
CSLASX: CSL: Develops and manufactures biopharmaceutical products and vaccines.
5+ YOERegulatory CMC leadership role requiring 5+ years in regulatory affairs for biologics/plasma, with cross-functional collaboration and international submissions.
Regulatory submissions, Regulatory intelligence, Change control, Due diligence, SOPs
Korsana BiosciencesNASDAQ: CYCN: Develops novel therapies to treat neurodegenerative diseases.
15+ YOE5+ MgmtPh.D. in relevant sciences or equivalent MS/BS experience; 15+ years in biologics development and manufacturing, including 5+ years as a CMC head; successful IND, IMPD, BLA, or MAA submissions and approvals.
AstraZenecaLondon Stock Exchange: AZN: Researches, develops, and manufactures prescription medicines for major diseases.
7+ YOE7+ years pharmaceutical/biopharma CMC experience, bachelor\u0002s required (advanced degree preferred), IND/IMPD and IND-enabling experience, process and analytical development, cross-functional leadership and regulatory authorship experience.
AstraZenecaLondon Stock Exchange: AZN: Researches and develops medicines to treat major diseases globally.
7+ YOE7+ years pharmaceutical/biopharma CMC development and manufacturing experience; Bachelor\u0002s required (advanced degree preferred); IND-enabling and process/analytical development experience; cross-functional leadership and strategic decision-making.
Vor BioNASDAQ: VOR: Developing targeted therapies for chronic autoimmune diseases.
8+ YOEDoctorate preferred; ≥8 years Regulatory CMC biologics experience with FDA sCDER interactions, global submissions, lifecycle management, and biologics/combination product development.
Xenon PharmaceuticalsNASDAQ: XENE: Developing therapeutics for neurological and psychiatric disorders.
10+ YOEPhD in Chemistry or Chemical Engineering with 10+ years API CDMO experience; regulatory CMC writing; CDMO selection and tech transfer; extensive cGMP knowledge.
CRISPR TherapeuticsNASDAQ: CRSP: Develops gene-editing medicines using the CRISPR/Cas9 platform.
12+ YOEBachelor's in relevant science required; 12+ years regulatory CMC experience (10+ with advanced degree); direct CMC experience for biologics/cell & gene therapies; knowledge of FDA/EMA/ICH and eCTD submissions.
Oruka TherapeuticsNASDAQ: ORKA: Develops long-acting biologics for chronic skin and inflammatory diseases.
6+ YOEMaster's or PhD in life sciences, 6+ years CMC experience with minimum 3+ years regulatory CMC in biologics, cGMP and global regulatory submission expertise (FDA/EMA/ICH), experience authoring Module 3 and combination product submissions.
Rapport TherapeuticsNASDAQ: RAPP: Developing precision medicines for neurological and psychiatric disorders.
12+ YOEBachelor’s degree in a scientific discipline and 12+ years of Regulatory CMC experience in biotech or pharma, including global registration, submissions, health authority interactions, and cross-functional leadership.
FDA, EMA, ICH, INDs, IMPDs, NDA, MAA, CTD Module 3
Madrigal PharmaceuticalsNASDAQ: MDGL: Develops and commercializes therapeutics for metabolic dysfunction-associated steatohepatitis.
12+ YOEBS in life sciences or equivalent experience (advanced degree preferred); minimum 12 years relevant experience with 8-10 years regulatory CMC experience; strategic CMC regulatory expertise; experience with global health authorities; strong communication and negotiation skills.
Broadmeadows or King of Prussia or Melbourne or Waltham
OnsiteFull Time
CSLASX: CSL: Global biotechnology producing plasma-derived and recombinant therapies.
5+ YOEBachelor's degree in biological or chemical sciences or related field; 5+ years of progressive regulatory experience in biologics or plasma; expertise in global regulations, CMC submissions, compliance, and cross-functional leadership.
AstraZenecaLondon Stock Exchange: AZN: Global biopharmaceutical developing and manufacturing prescription medicines.
7+ YOE7+ years pharmaceutical product development and manufacturing experience; Bachelor's degree required (advanced degree preferred); IND-enabling CMC, process and analytical development, project leadership, cross-functional collaboration.
Cambridge or Research Triangle Park or San Francisco
$204k-$281k/yrHybridFull Time
BiogenNASDAQ: BIIB: Develops therapies for neurological and neurodegenerative diseases.
12+ YOE12+ years' experience in matrix leadership with CMC/supply chain or life cycle management; BS required, advanced degree preferred; alliance and financial management experience; strong strategic, communication and risk-management skills.
AbbVieNYSE: ABBV: Develops and sells innovative pharmaceutical and biopharmaceutical medicines.
12+ YOEExtensive CMC leadership for small molecule development through IND/NDA/MAA; technical, regulatory and project leadership with strong communication and strategic skills.
Crescent BiopharmaNASDAQ: CBIO: Develops novel oncology therapies and antibody-drug conjugates for cancer.
12+ YOE12+ years regulatory affairs CMC experience in pharma/biotech, advanced scientific degree required, strong regulatory negotiation and submission experience (INDs/BLAs/MAAs), leadership and communication skills.
Beam TherapeuticsNASDAQ: BEAM: Develops precision genetic medicines using base editing technology.
10+ YOEAdvanced degree in life sciences or engineering,10+ years CMC development experience with leadership, expertise in nucleic acid/LNP manufacturing and analytics, regulatory submission experience, strong risk management and communication skills.
Alnylam PharmaceuticalsNASDAQ: ALNY: Develops RNAi therapeutics to treat rare and common diseases.
8+ YOEAdvanced degree in a relevant scientific discipline, 8+ years industry experience including 5+ years in Regulatory Affairs CMC, experience with regulatory submissions and health authority interactions, strong communication and cross-functional leadership.